The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease?
Abstract
Multiple sclerosis is (MS) a T‐cell autoimmune disease characterized by a relapsing‐remitting followed by a progressive phase. Relapses are driven by the adaptive immune system and involve waves of T helper cell 1 (Th1), Th17, and CD8 cells that infiltrate the nervous system and provoke a attack. These cells are modulated by regulatory T and B cells. Infiltration of T cells into the nervous system initiates a complex immunological cascade consisting of epitope spreading, which triggers new attacks, and activation of the innate immune system (microglia, dendritic cells, astrocytes, B cells), which leads to chronic inflammation. The secondary progressive phase is due to neurodegeneration triggered by inflammation and is driven by the innate immune system. Why a shift to the progressive stage occurs and how to prevent it is a central question in MS. Effective treatment of MS must affect multiple disease pathways: suppression of proinflammatory T cells, induction of regulatory T cells, altering traffic of cells into the nervous system, protecting axons and myelin, and controlling innate immune responses. Without biomarkers, the clinical and pathological heterogeneity of MS makes treatment difficult. Treatment is further hampered by untoward adverse effects caused by immune suppression. Nonetheless, major progress has been made in the understanding and treatment of MS. There are three definitions of cure as it applies to MS: (1) halt progression of disease, (2) reverse neurological deficits, and (3) prevent MS. Although the pathways to each of these cures are linked, each requires a unique strategy. Ann Neurol 2009;65:239–248
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Multiple Sclerosis and Epstein-Barr Virus
Levin, L. I., Munger, K. L., Rubertone, M. V., Peck, C. A., Lennette, E. T., Spiegelman, D., & Ascherio, A. (2003) · JAMA · doi:10.1001/jama.289.12.1533 · Cited by 165
RetractedBettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Self-citationRegulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,325
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439
Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M., Oukka, M., & Weiner, H. L. (2008) · Nature · doi:10.1038/nature06880 · Cited by 1,865
Self-citationLoss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856
Self-citationCortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746
Magliozzi, R., Howell, O., Vora, A., Serafini, B., Nicholas, R., Puopolo, M., Reynolds, R., & Aloisi, F. (2006) · Brain · doi:10.1093/brain/awm038 · Cited by 1,443
Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis
Rudick, R. A., Stuart, W. H., Calabresi, P. A., Confavreux, C., Galetta, S. L., Radue, E.-W., Lublin, F. D., Weinstock-Guttman, B., Wynn, D. R., Lynn, F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044396 · Cited by 1,344
Relapses and Progression of Disability in Multiple Sclerosis
Confavreux, C., Vukusic, S., Moreau, T., & Adeleine, P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432001 · Cited by 1,309
Induction and effector functions of TH17 cells
Bettelli, E., Korn, T., Oukka, M., & Kuchroo, V. K. (2008) · Nature · doi:10.1038/nature07036 · Cited by 1,216
The Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans
Grazia Roncarolo, M., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K., & Levings, M. K. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00420.x · Cited by 1,173
Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802670 · Cited by 1,017
Multiple sclerosis: a complicated picture of autoimmunity
McFarland, H. F., & Martin, R. (2007) · Nature Immunology · doi:10.1038/ni1507 · Cited by 985
Identification of autoantibodies associated with myelin damage in multiple sclerosis
Genain, C. P., Cannella, B., Hauser, S. L., & Raine, C. S. (1999) · Nature Medicine · doi:10.1038/5532 · Cited by 892
Induction and mechanism of action of transforming growth factor‐β‐secreting Th3 regulatory cells
Weiner, H. L. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820117.x · Cited by 846
Self-citationHauser, S. L., Dawson, D. M., Lehrich, J. R., Beal, M. F., Kevy, S. V., Propper, R. D., Mills, J. A., & Weiner, H. L. (1983) · New England Journal of Medicine · doi:10.1056/nejm198301273080401 · Cited by 827
Self-citationBettelli, E., Pagany, M., Weiner, H. L., Linington, C., Sobel, R. A., & Kuchroo, V. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021603 · Cited by 825
Self-citationPrimary-progressive multiple sclerosis
Miller, D. H., & Leary, S. M. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70243-0 · Cited by 818
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation
Korn, T., Reddy, J., Gao, W., Bettelli, E., Awasthi, A., Petersen, T. R., Bäckström, B. T., Sobel, R. A., Wucherpfennig, K. W., Strom, T. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1564 · Cited by 811
Glutamate excitotoxicity in a model of multiple sclerosis
Pitt, D., Werner, P., & Raine, C. S. (2000) · Nature Medicine · doi:10.1038/71555 · Cited by 744
Autoantigen microarrays for multiplex characterization of autoantibody responses
Robinson, W. H., DiGennaro, C., Hueber, W., Haab, B. B., Kamachi, M., Dean, E. J., Fournel, S., Fong, D., Genovese, M. C., De Vegvar, H. E. N., et al. (2002) · Nature Medicine · doi:10.1038/nm0302-295 · Cited by 673
Duddy, M., Niino, M., Adatia, F., Hebert, S., Freedman, M., Atkins, H., Kim, H. J., & Bar-Or, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6092 · Cited by 653
Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells
Stromnes, I. M., Cerretti, L. M., Liggitt, D., Harris, R. A., & Goverman, J. M. (2008) · Nature Medicine · doi:10.1038/nm1715 · Cited by 630
Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis
Misu, T., Fujihara, K., Kakita, A., Konno, H., Nakamura, M., Watanabe, S., Takahashi, T., Nakashima, I., Takahashi, H., & Itoyama, Y. (2007) · Brain · doi:10.1093/brain/awm047 · Cited by 614
CLINICAL VIRAL INFECTIONS AND MULTIPLE SCLEROSIS
SIBLEY, W. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92801-6 · Cited by 594
Mizoguchi, A., & Bhan, A. K. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.705 · Cited by 582
Bjartmar, C., Wujek, J. R., & Trapp, B. D. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00069-2 · Cited by 573
Mi, S., Hu, B., Hahm, K., Luo, Y., Kam Hui, E. S., Yuan, Q., Wong, W. M., Wang, L., Su, H., Chu, T.-H., et al. (2007) · Nature Medicine · doi:10.1038/nm1664 · Cited by 492
Steinman, L., & Zamvil, S. S. (2006) · Annals of Neurology · doi:10.1002/ana.20913 · Cited by 479
Autoimmune encephalomyelitis ameliorated by AMPA antagonists
Smith, T., Groom, A., Zhu, B., & Turski, L. (2000) · Nature Medicine · doi:10.1038/71548 · Cited by 467
Association between parasite infection and immune responses in multiple sclerosis
Correale, J., & Farez, M. (2007) · Annals of Neurology · doi:10.1002/ana.21067 · Cited by 467
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein
O'Connor, K. C., McLaughlin, K. A., De Jager, P. L., Chitnis, T., Bettelli, E., Xu, C., Robinson, W. H., Cherry, S. V., Bar-Or, A., Banwell, B., et al. (2007) · Nature Medicine · doi:10.1038/nm1488 · Cited by 416
Hiscock, C., & ISDALE, I. C. (1964) · PubMed · Cited by 370
Hinson, S. R., Roemer, S. F., Lucchinetti, C. F., Fryer, J. P., Kryzer, T. J., Chamberlain, J. L., Howe, C. L., Pittock, S. J., & Lennon, V. A. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081241 · Cited by 355
Homogeneity of active demyelinating lesions in established multiple sclerosis
Breij, E. C. W., Brink, B. P., Veerhuis, R., van den Berg, C., Vloet, R., Yan, R., Dijkstra, C. D., van der Valk, P., & Bö, L. (2008) · Annals of Neurology · doi:10.1002/ana.21311 · Cited by 353
Gray matter involvement in multiple sclerosis
Pirko, I., Lucchinetti, C. F., Sriram, S., & Bakshi, R. (2007) · Neurology · doi:10.1212/01.wnl.0000250267.85698.7a · Cited by 349
MRI in multiple sclerosis: current status and future prospects
Bakshi, R., Thompson, A. J., Rocca, M. A., Pelletier, D., Dousset, V., Barkhof, F., Inglese, M., Guttmann, C. R., Horsfield, M. A., & Filippi, M. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70137-6 · Cited by 348
Bettelli, E., Baeten, D., Jäger, A., Sobel, R. A., & Kuchroo, V. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28334 · Cited by 336
Evidence for synaptic stripping by cortical microglia
Trapp, B. D., Wujek, J. R., Criste, G. A., Jalabi, W., Yin, X., Kidd, G. J., Stohlman, S., & Ransohoff, R. (2007) · Glia · doi:10.1002/glia.20462 · Cited by 322
Balashov, K. E., Smith, D. R., Khoury, S. J., Hafler, D. A., & Weiner, H. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.599 · Cited by 320
Self-citationLipid microarrays identify key mediators of autoimmune brain inflammation
Kanter, J. L., Narayana, S., Ho, P. P., Catz, I., Warren, K. G., Sobel, R. A., Steinman, L., & Robinson, W. H. (2006) · Nature Medicine · doi:10.1038/nm1344 · Cited by 317
Iron in Chronic Brain Disorders: Imaging and Neurotherapeutic Implications
Stankiewicz, J., Panter, S. S., Neema, M., Arora, A., Batt, C. E., & Bakshi, R. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.05.006 · Cited by 301
HLA-DR2 Dose Effect on Susceptibility to Multiple Sclerosis and Influence on Disease Course
Barcellos, L. F., Oksenberg, J. R., Begovich, A. B., Martin, E. R., Schmidt, S., Vittinghoff, E., Goodin, D. S., Pelletier, D., Lincoln, R. R., Bucher, P., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/367781 · Cited by 293
Multiple Sclerosis Is an Inflammatory T-Cell–Mediated Autoimmune Disease
Weiner, H. L. (2004) · Archives of Neurology · doi:10.1001/archneur.61.10.1613 · Cited by 293
Self-citationAlterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis
Astier, A. L., Meiffren, G., Freeman, S., & Hafler, D. A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29251 · Cited by 292
New natural history of interferon‐β–treated relapsing multiple sclerosis
Trojano, M., Pellegrini, F., Fuiani, A., Paolicelli, D., Zipoli, V., Zimatore, G. B., Di Monte, E., Portaccio, E., Lepore, V., Livrea, P., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21102 · Cited by 270
Hawkins, S. A., & McDonnell, G. V. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.2.148 · Cited by 260
Vaknin-Dembinsky, A., Balashov, K., & Weiner, H. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7768 · Cited by 259
Self-citationWarrington, A. E., Asakura, K., Bieber, A. J., Ciric, B., Van Keulen, V., Kaveri, S. V., Kyle, R. A., Pease, L. R., & Rodriguez, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6820 · Cited by 254
Crawford, M. P., Yan, S. X., Ortega, S. B., Mehta, R. S., Hewitt, R. E., Price, D. A., Stastny, P., Douek, D. C., Koup, R. A., Racke, M. K., et al. (2004) · Blood · doi:10.1182/blood-2003-11-4025 · Cited by 250
Sodium channels contribute to microglia/macrophage activation and function in EAE and MS
Craner, M. J., Damarjian, T. G., Liu, S., Hains, B. C., Lo, A. C., Black, J. A., Newcombe, J., Cuzner, M. L., & Waxman, S. G. (2005) · Glia · doi:10.1002/glia.20112 · Cited by 249
Quintana, F. J., Farez, M. F., Viglietta, V., Iglesias, A. H., Merbl, Y., Izquierdo, G., Lucas, M., Basso, A. S., Khoury, S. J., Lucchinetti, C. F., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806310105 · Cited by 241
Self-citationReversal of axonal loss and disability in a mouse model of progressive multiple sclerosis
Basso, A. S., Frenkel, D., Quintana, F. J., Costa-Pinto, F. A., Petrovic-Stojkovic, S., Puckett, L., Monsonego, A., Bar-Shir, A., Engel, Y., Gozin, M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33464 · Cited by 237
Self-citationOral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+CD25−LAP+ T cells
Ochi, H., Abraham, M., Ishikawa, H., Frenkel, D., Yang, K., Basso, A. S., Wu, H., Chen, M.-L., Gandhi, R., Miller, A., et al. (2006) · Nature Medicine · doi:10.1038/nm1408 · Cited by 236
Self-citationMiller, D. H., Thompson, A. J., & Filippi, M. (2003) · Journal of Neurology · doi:10.1007/s00415-003-0243-9 · Cited by 235
The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination
Karnezis, T., Mandemakers, W., McQualter, J. L., Zheng, B., Ho, P. P., Jordan, K. A., Murray, B. M., Barres, B., Tessier-Lavigne, M., & Bernard, C. C. A. (2004) · Nature Neuroscience · doi:10.1038/nn1261 · Cited by 230
Persistent inflammation alters the function of the endogenous brain stem cell compartment
Pluchino, S., Muzio, L., Imitola, J., Deleidi, M., Alfaro-Cervello, C., Salani, G., Porcheri, C., Brambilla, E., Cavasinni, F., Bergamaschi, A., et al. (2008) · Brain · doi:10.1093/brain/awn198 · Cited by 226
Interferon beta-1b in secondary progressive MS: A combined analysis of the two trials
Kappos, L., Weinshenker, B., Pozzilli, C., Thompson, A. J., Dahlke, F., Beckmann, K., Polman, C., & McFarland, H. (2004) · Neurology · doi:10.1212/01.wnl.0000145561.08973.4f · Cited by 224
Comabella, M., Balashov, K., Issazadeh, S., Smith, D., Weiner, H. L., & Khoury, S. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3125 · Cited by 221
Self-citationClinical implications of benign multiple sclerosis: A 20‐year population‐based follow‐up study
Pittock, S. J., McClelland, R. L., Mayr, W. T., Jorgensen, N. W., Weinshenker, B. G., Noseworthy, J., & Rodriguez, M. (2004) · Annals of Neurology · doi:10.1002/ana.20197 · Cited by 211
(2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00448.x · Cited by 201
Mechanisms of Disease: sodium channels and neuroprotection in multiple sclerosis—current status
Waxman, S. G. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0735 · Cited by 192
Murugaiyan, G., Mittal, A., & Weiner, H. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7480 · Cited by 187
Self-citationVenken, K., Hellings, N., Hensen, K., Rummens, J., Medaer, R., D'hooghe, M. B., Dubois, B., Raus, J., & Stinissen, P. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20852 · Cited by 185
Karni, A., Abraham, M., Monsonego, A., Cai, G., Freeman, G. J., Hafler, D., Khoury, S. J., & Weiner, H. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.4196 · Cited by 177
Self-citationBlood transcriptional signatures of multiple sclerosis: Unique gene expression of disease activity
Achiron, A., Gurevich, M., Friedman, N., Kaminski, N., & Mandel, M. (2004) · Annals of Neurology · doi:10.1002/ana.20008 · Cited by 171
Weiner, H. L., & Cohen, J. A. (2002) · Multiple Sclerosis Journal · doi:10.1191/1352458502ms790oa · Cited by 158
Self-citationGauthier, S. A., Glanz, B. I., Mandel, M., & Weiner, H. L. (2006) · Autoimmunity Reviews · doi:10.1016/j.autrev.2006.02.012 · Cited by 153
Self-citationSaxena, A., Bauer, J., Scheikl, T., Zappulla, J. P., Audebert, M., Desbois, S., Waisman, A., Lassmann, H., Liblau, R., & Mars, L. T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.1617 · Cited by 145
IL‐10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis
Martínez‐Forero, I., García‐Muñoz, R., Martinez‐Pasamar, S., Inogés, S., de Cerio, A. L.-D., Palacios, R., Sepulcre, J., Moreno, B., Gonzalez, Z., Fernández-Díez, B., et al. (2008) · European Journal of Immunology · doi:10.1002/eji.200737271 · Cited by 141
Uncoupling the Roles of HLA-DRB1 and HLA-DRB5 Genes in Multiple Sclerosis
Caillier, S. J., Briggs, F. B. S., Cree, B., Baranzini, S. E., Fernández-Viña, M., Ramsay, P. P., Khan, O. A., Royal, W., Hauser, S. L., Barcellos, L. F., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5473 · Cited by 140
Longitudinal MRI in multiple sclerosis
Khoury, S. J., Guttmann, C. R. G., Orav, E. J., Hohol, M. J., Ahn, S. S., Hsu, L., Kikinis, R., Mackin, G. A., Jolesz, F. A., & Weiner, H. L. (1994) · Neurology · doi:10.1212/wnl.44.11.2120 · Cited by 134
Self-citationMontes, M., Zhang, X., Berthelot, L., Laplaud, D. A., Brouard, S., Jin, J., Rogan, S. C., Armao, D. M., Jewells, V. L., Soulillou, J., et al. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.08.030 · Cited by 134
Corvol, J., Pelletier, D., Henry, R. G., Caillier, S. J., Wang, J., Pappas, D. J., Casazza, S., Okuda, D. T., Hauser, S. L., Oksenberg, J. R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805065105 · Cited by 126
Benign course in multiple sclerosis: a review
Ramsaransing, G. S. M., & Keyser, J. D. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00637.x · Cited by 122
COMBINING BETA INTERFERON AND ATORVASTATIN MAY INCREASE DISEASE ACTIVITY IN MULTIPLE SCLEROSIS
Salvatore, E., Morra, V. B., & Orefice, G. (2009) · Neurology · doi:10.1212/wnl.0b013e3181ab6e08 · Cited by 121
Experimental models of multiple sclerosis
Lassmann, H. (2007) · Revue Neurologique · doi:10.1016/s0035-3787(07)90474-9 · Cited by 121
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis
Birnbaum, G., Cree, B., Altafullah, I., Zinser, M., & Reder, A. T. (2008) · Neurology · doi:10.1212/01.wnl.0000319698.40024.1c · Cited by 117
Changes in Activated T Cells in the Blood Correlate With Disease Activity in Multiple Sclerosis
Khoury, S. J., Guttmann, C. R. G., Orav, E. J., Kikinis, R., Jolesz, F. A., & Weiner, H. L. (2000) · Archives of Neurology · doi:10.1001/archneur.57.8.1183 · Cited by 108
Self-citationKarni, A. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00018-8 · Cited by 95
Immunosuppression promotes CNS remyelination in chronic virus‐induced demyelinating disease
Rodriguez, M., & Lindsley, M. D. (1992) · Neurology · doi:10.1212/wnl.42.2.348 · Cited by 76
Role of natural killer cells in the pathogenesis and progression of multiple sclerosis
Morandi, B., Bramanti, P., Bonaccorsi, I., Montalto, E., Oliveri, D., Pezzino, G., Navarra, M., & Ferlazzo, G. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.11.003 · Cited by 65
Bakshi, R., Neema, M., Healy, B. C., Liptak, Z., Betensky, R. A., Buckle, G. J., Gauthier, S. A., Stankiewicz, J. M., Meier, D., Egorova, S., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1449 · Cited by 54
Self-citationRate of Brain Atrophy in Benign vs Early Multiple Sclerosis
Gauthier, S. A., Berger, A. M., Liptak, Z., Duan, Y., Egorova, S., Buckle, G. J., Glanz, B. I., Khoury, S. J., Bakshi, R., Weiner, H. L., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.567 · Cited by 51
Self-citationLiptak, Z., Berger, A. M., Sampat, M. P., Charil, A., Felsovalyi, O., Healy, B. C., Hildenbrand, P. G., Khoury, S. J., Weiner, H. L., Bakshi, R., et al. (2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1162 · Cited by 43
Self-citationA Novel Model of Demyelinating Encephalomyelitis Induced by Monocytes and Dendritic Cells
Furtado, G. C., Piña, B., Tacke, F., Gaupp, S., van Rooijen, N., Moran, T. M., Randolph, G. J., Ransohoff, R. M., Chensue, S. W., Raine, C. S., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6871 · Cited by 42
MRI of Spinal Cord in Multiple Sclerosis
Agosta, F., & Filippi, M. (2007) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2007.00137.x · Cited by 34
Cited by
The immunology of stroke: from mechanisms to translation
Iadecola, C., & Anrather, J. (2011) · Nature Medicine · doi:10.1038/nm.2399 · Cited by 2,596
An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis
Schmidt, P., Gaser, C., Arsic, M., Buck, D., Förschler, A., Berthele, A., Hoshi, M., Ilg, R., Schmid, V. J., Zimmer, C., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.11.032 · Cited by 1,223
Evidence for a two-stage disability progression in multiple sclerosis
Leray, E., Yaouanq, J., Le Page, E., Coustans, M., Laplaud, D., Oger, J., & Edan, G. (2010) · Brain · doi:10.1093/brain/awq076 · Cited by 596
Cannabinoids as Novel Anti-Inflammatory Drugs
Nagarkatti, P., Pandey, R., Rieder, S. A., Hegde, V. L., & Nagarkatti, M. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.93 · Cited by 555
“Multiple sclerosis (MS) is an autoimmune disorder that is mediated by myelin-specific selfreactive T cells, macrophages/microglial cells and astrocytes [3,42].”
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation
Mayo, L., Trauger, S. A., Blain, M., Nadeau, M., Patel, B., Alvarez, J. I., Mascanfroni, I. D., Yeste, A., Kivisäkk, P., Kallas, K., et al. (2014) · Nature Medicine · doi:10.1038/nm.3681 · Cited by 472
Self-citation
Metadata
- Authors
- Weiner, H. L.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2009-03
- Volume
- 65
- Issue
- 3
- Pages
- 239-248
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1992692157
- Cited by
- 344
- References
- 91
- FWCI
- 28.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.